LivingGLP1
Study S002536

Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors Agonists

Registration

Registration
NCT07506356
Acronym
SAGUSE
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
38
Start
2026-04-01
Primary completion
2026-12-31
Lead sponsor
University Hospital, Geneva
Conditions
Diabete Type 2; Regurgitation; Pulmonary Aspiration During Anaesthetic Induction
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
NIH:2025

Registered primary outcomes

  • A safe gastric volume for anesthesia in diabetic patients treated with GLP-1 analog after a 6 hours fasting period 7 day after the last injection. [1 week]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.